BOUL logo

Boule Diagnostics AB (publ) Stock Price

OM:BOUL Community·SEK 153.8m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

BOUL Share Price Performance

SEK 3.96
-4.80 (-54.79%)
SEK 7.50
Fair Value
SEK 3.96
-4.80 (-54.79%)
47.2% undervalued intrinsic discount
SEK 7.50
Fair Value
Price SEK 3.96
AnalystConsensusTarget SEK 7.50

BOUL Community Narratives

AnalystConsensusTarget·
Fair Value SEK 7.5 47.2% undervalued intrinsic discount

Decentralized Diagnostics And Recurring Consumables Revenue Will Drive Stronger Margins Ahead

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Trending Discussion

Updated Narratives

BOUL logo

Decentralized Diagnostics And Recurring Consumables Revenue Will Drive Stronger Margins Ahead

Fair Value: SEK 7.5 47.2% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with reasonable growth potential.

1 Risk
3 Rewards

Boule Diagnostics AB (publ) Key Details

SEK 489.7m

Revenue

SEK 275.9m

Cost of Revenue

SEK 213.8m

Gross Profit

SEK 217.6m

Other Expenses

-SEK 3.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 10, 2026
-0.098
43.66%
-0.78%
112.5%
View Full Analysis

About BOUL

Founded
1956
Employees
200
CEO
Torben Nielsen
WebsiteView website
www.boule.com

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.

Recent BOUL News & Updates

Recent updates

No updates